Specialty drug costs nearly tripled over six years, while opioid utilization dropped and prescribing patterns shifted based on claim stage, according to Enlyte.

A narrow focus on the opioid epidemic may overlook the risks of non-opioid prescriptions and draw crucial resources away from proactive monitoring and interventions.

This National Comp 2023 session looks to reflect on the most prominent workers’ comp medical trends of today. 

After years of tightening limits, new federal guidelines are giving doctors greater leeway in prescribing opioids. Workers’ comp experts dive in to see how this could impact the industry.

Is it time to change our relationship to NSAIDs, like Advil? What are the alternatives?

The latest trends in the ongoing battle over liability in America’s opioid abuse epidemic.

Movement therapies have innumerable benefits on their own. Here’s how they are helping in the fight against the opioid epidemic.

When Max Tillitt succumbed to opioid addiction, his mother took their insurance to court after it allegedly cut Tillitt’s recovery funds short.

At RIMS 2022, Dorothy Riviere, chief clinical officer of Bardavon Health, spoke about PT and pain management, and the need to better educate injured workers.

The big pharmacies in the U.S. are next in line for opioid crisis scrutiny as more and more states sue responsible parties.

Amazon to pay $2.25 million and cease “Sold by Amazon” operations after Washington state AG files antitrust suit accusing the online retailer of price fixing.

Physical therapy and pain management intervention proved productive in replacing opioids as methods to control pain in injured workers.

The latest court filings and cases that will have an impact on the risk management and insurance industry.

Johnson & Johnson, Cardinal Health, AmerisourceBergen and McKesson have reached a $26 billion deal with state attorneys general that would release them from all civil liability in the opioid epidemic.

The latest court filings and cases that will have an impact on the risk management and insurance industry.

When Purdue Pharma was first sussed out as a leading cause of the opioid epidemic in the U.S., it wouldn’t be long until the pharmaceutical company’s partners were feeling the heat. 

The opioid misuse crisis continues to negatively impact the lives of patients while costing our health care system billions of dollars. This is why it still deserves our focus.

Join myMatrixx’s Phil Walls and The Hartford’s Adam Seidner as they explore alternative approaches to opioid pain management in workers’ compensation claims.

A CompTalk presented by the National Comp Conference dives into fentanyl’s transformation into one of the deadliest opioids in today’s epidemic.

A new report concluded that COVID-19 has led to increased opioid abuse, medical marijuana legislation and drugs delivered by mail.